About AstraZeneca Tezspire
The next era of severe asthma management has emerged.
Rise above the complexity
THE FIRST AND ONLY biologic approved for severe asthma without phenotypic or biomarker limitations1TEZSPIRE targets and blocks TSLP at the top of the inflammatory cascade.
TEZSPIRE reduces the release of downstream mediators to impact TWO hallmarks of asthma.
